Anxiety / stress response Investigated as an anxiolytic in Russian clinical research on generalized anxiety
Instead GHK seems to have a more multi-faceted effect on many different systems
Predrag Sikiric, Sven Seiwerth, Zeljko Grabarevic, Petek, M., Rucman, R., Turkovic, B., Ivo Rotkvic, Vjekoslav Jagic, Duvnjak, M., Mise, S., Sanja Djacic, Jadranka Separovic, Marija Veljaca, Ahmet Sallmani, Banic, M., & Brkic, T
Theoretical Risks with Chronic Use Some concerns raised by clinicians and researchers include: Unregulated angiogenesis: Overstimulation of blood vessel growth could hypothetically support tumor progression in cancer-prone individuals Unknown hormonal crosstalk: While BPC-157 is non-hormonal, it interacts with systems (e.g., nitric oxide, dopamine) that may influence downstream signaling Immune tolerance or desensitization: Chronic exposure to any peptide could alter immune recognition or receptor sensitivity over time These concerns are theoretical , but they highlight why BPC-157 should not be used indefinitely or in uncontrolled cycles
This level of professional guidance is what separates real peptide therapy from self-experimentation
3C), 12 mg/kg (FIG